Overview


According to FutureWise analysis the market for drug of abuse testing in 2023 is US$ 10.12 billion, and is expected to reach US$ 19.3 billion by 2031 at a CAGR of 8.40%.

Drug abuse refers to the excessive, maladaptive, or addictive consumption of substances for nonmedical purposes, disregarding the potential social, physical, and psychological consequences of such usage. This harmful behaviour involves a range of substances, including anabolic steroids, utilized by certain athletes to expedite muscle growth and enhance strength; however, these steroids can lead to conditions such as heart disease and liver damage. Additionally, psychotropic agents are substances affecting the user's mental state and are employed to induce alterations in mood, perception, and emotions. The group encompasses opium and its derivatives like heroin, hallucinogens, barbiturates, cocaine, amphetamines, tranquilizers, various forms of cannabis, and alcohol. A drug test examines a sample of urine, blood, saliva, hair, or sweat to detect signs of illegal or prescription drug use or misuse, which includes using illicit substances or misusing prescription medications. Drug tests can identify individual drugs or groups of drugs, such as alcohol, amphetamines, barbiturates, benzodiazepines, cocaine, marijuana (THC), opioids, phencyclidine (PCP), and steroids. Usually, urine samples are used, allowing detection within hours to several days before the test, depending on factors like drug type, usage amount, duration, and individual response. Drug testing serves various purposes, including pre-employment screening, on-the-job testing, sports doping checks, monitoring drug treatment, legal investigations, and verifying the proper use of prescription medications. Tests can be scheduled or conducted randomly. It's important to note that while drug testing can indicate drug use or misuse, it cannot diagnose a drug use disorder.

FutureWise Market Research has published a report that provides an insightful analysis of Drug of Abuse Testing Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

By the end of the forecast period FutureWise research analysts projects that Drug of Abuse Testing Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Thermo Fisher Scientific
  • SYNLAB
  • Siemens Healthcare Private Limited
  • Roche Diagnostics
  • Dragerwerk AGCo KGaA
  • Beckman Coulter Inc
  • Abbott Laboratories
  • Express Diagnostics International Inc
  • Shimadzu Corporation
  • Laboratory Corporation of America
  • Clinical Reference Laboratory (CRL),Inc
  • Cordant Health Solutions
  • Legacy Medical Services
  • Millennium Health
  • American Substance Abuse professional (ASAP), Inc

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Development in Drug of Abuse Testing Market

  • In August 2022, the Delaware Division of Public Health initiated a significant step by introducing fentanyl strips as part of Narcan kits distributed to the general public. This proactive approach formed a crucial component of a harm-reduction strategy, explicitly targeting the reduction of unintentional overdose incidents linked to the consumption of fentanyl.
  • In June 2022, the government of Punjab in India embarked on a noteworthy initiative involving comprehensive drug screening within correctional facilities. This endeavor aimed to identify instances of drug abuse among inmates. This widespread screening effort, encompassing more than 8,000 prisoners across 14 jails, yielded compelling results. The findings revealed that a substantial proportion, approximately 42%, of the incarcerated individuals were grappling with drug addiction.

By Drug Type

  • Alcohol
  • Cocaine
  • Marijuana/Cannabis
  • LSD
  • Opioids
  • Others

By Product

  • Analyzers
    • Immunoassay Analyzers
    • Chromatographic Devices
    • Breath Analyzers
  • Rapid Testing Devices
    • Urine Testing Devices
    • Oral Fluid Testing Devices
  • Consumables

By Sample Type

  • Saliva
  • Urine
  • Blood
  • Other Sample Types

By End-User

  • Hospitals
  • Rehabilitation Centers
  • Federal Agencies
  • Forensic Laboratories
  • Clinics
  • Hospitals
  • Others

By Application

  • Pain Management Testing
  • Criminal Justice Testing
  • Workplace Screening

By Region

  • Europe
  • North America
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. In 2022, North America asserted its dominance in the drugs of abuse (DOA) testing market, commanding over 39% of the share. This commanding position can be attributed to a confluence of factors that create a favorable environment for DOA testing expansion. The region's unfortunate high availability of illegal substances and the escalating incidence of drug trafficking have spurred an urgent need for stringent monitoring mechanisms. Additionally, the growing emphasis on workplace safety and compliance has prompted organizations to adopt comprehensive drug testing protocols, further fueling the demand for DOA testing services. This has positioned North America as a hub of DOA testing activity, reflecting both the troubling challenges posed by substance abuse and the proactive measures being taken to curb its impact on various facets of society. Moreover, by drug type, Cannabis accounted for the highest share in the market in 2022, with more than 27% share globally, due to its widespread cultivation, trafficking, and abuse. As the most commonly used illicit drug globally, it's linked to half of all drug seizures. According to WHO, around 147 million people, 2.5% of the global population, consume cannabis annually, surpassing cocaine and opiate consumption.

Drivers for Drug of Abuse Testing Market

Drug abuse testing market is witnessing robust growth driven by a convergence of factors linked to the increasing awareness and initiatives aimed at countering substance misuse in various countries. A key catalyst is the heightened acknowledgment of drug addiction's severe health and societal repercussions, example being India's response to the opioid epidemic elevating the significance of drug testing. Notably, opioid substitution therapy programs have been implemented to offer safer alternatives for those battling addiction. Furthermore, the imperative of workplace safety is amplifying the demand for drug testing, particularly in sectors like transportation and manufacturing, where impairment poses substantial risks. Noteworthy examples include the Indian Railways, a major employer, which has instituted routine drug testing to bolster safety measures and prevent accidents from impaired employees. Additionally, regulatory mandates, such as the Narcotic Drugs and Psychotropic Substances Act, have propelled drug abuse testing, which is pivotal in law enforcement's fight against drug trafficking and misuse. Concurrently, the Ministry of Road Transport and Highways' proposal for mandatory drug testing among commercial vehicle drivers underscores efforts to enhance road safety by curbing impaired driving incidents.

Restraints for Drug of Abuse Testing Market

Drug testing encounters several restraints that impact its acceptance and effectiveness. One primary concern is the potential invasion of personal privacy and the associated stigma. Individuals subjected to testing may fear disclosing their results, leading to reluctance to participate. This is evident in workplaces with random drug testing, where employees may perceive compromised privacy, resulting in diminished morale and apprehensions about their confidential information being divulged. Additionally, the issue of false positives and false negatives undermines the reliability of drug tests. These inaccuracies can trigger confusion, legal entanglements, and harm to personal or professional reputations. Such errors may wrongly implicate individuals in drug use due to a false positive outcome, subjecting them to unjust consequences.

Furthermore, the financial burden of implementing comprehensive drug testing programs poses a significant restraint, particularly for smaller organizations or healthcare facilities with limited budgets. The costs associated with equipment, training, sample analysis, and collection can be onerous, potentially hindering the establishment and sustainability of effective testing protocols. Lastly, legal and ethical considerations loom prominently. Navigating individual rights and consent issues is crucial in designing testing programs. In cases where protocols infringe on personal rights or lack proper consent, legal challenges can emerge, raising questions about invasiveness and potential discrimination. These multifaceted restraints underscore the complexities and challenges inherent in drug testing initiatives.

Opportunities for Drug of Abuse Testing Market

The drug abuse testing market is poised for significant opportunities driven by factors that tap into evolving needs and advancements. One such thing is the rise of remote and at-home testing, which presents a unique opportunity. Start-ups are capitalizing on this trend by developing user-friendly, mail-in drug testing kits that individuals can use in the privacy of their homes. This approach empowers concerned parents to monitor their teenagers' drug use discreetly and fosters open conversations about substance misuse. Integration with healthcare services offers another promising prospect. Primary care clinics can integrate drug testing as part of routine check-ups to detect early signs of substance use disorders. For instance, a family doctor might include drug testing as part of a teenager's annual physical exam to identify potential issues and initiate appropriate interventions.

In the realm of sports, drug testing continues to evolve. Advancements in testing technologies provide an opportunity to stay ahead of doping practices. Testing labs invest in cutting-edge mass spectrometry techniques to detect minute traces of performance-enhancing substances, ensuring a level playing field for athletes worldwide.

Customized testing panels cater to specific needs. For instance, construction companies operating in regions grappling with opioid epidemics might opt for drug testing panels specifically designed to detect opioid use, helping them address safety concerns and promote a drug-free workforce.

Trends for Drug of Abuse Testing Market

The drug testing market is undergoing technological advancements, encompassing sophisticated immunoassays, mass spectrometry techniques, and point-of-care devices, all elevating drug testing processes precision, sensitivity, and efficiency. Concurrently, the surge in synthetic drugs, spanning designer compounds and novel psychoactive substances (NPS), has prompted the expansion of testing panels. Laboratories are strategically broadening their scope to encompass diverse synthetic substances, aligning with emerging patterns. Furthermore, an integrated perspective linking mental health with substance use is gaining traction within specific drug testing programs. This comprehensive approach entails offering co-occurring disorder support and treatment referrals, recognizing the interplay between these interconnected facets. Additionally, the integration of pharmacogenomics is molding drug testing strategies, ushering in personalized medicine paradigms that leverage genetic information to inform medication choices, notably within addiction treatment.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • FutureWise research report will help you understand the growth prospects, key trends, and data points affecting the market's growth. 
  • A detailed review of strategies being opted by the players in this market, and a thorough market share registered by the key companies globally as well as on a regional basis.

  • To provide with an exhaustive analysis on the of Drug of Abuse Testing Market By Drug Type, By Product, By Sample Type, By Application, By End-User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Drug of Abuse Testing Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Drug of Abuse Testing Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Drug of Abuse Testing Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Drug of Abuse Testing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Drug of Abuse Testing Market, By Drug Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Alcohol
        2. Cocaine
        3. Marijuana/Cannabis
        4. LSD
        5 Opioids
        6 Others

  • 8.   Drug of Abuse Testing Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Analyzers
         1.1. Immunoassays Analyzers
         1.2. Chromatographic Devices
         1.3. Breath Analyzers
        2. Rapid Testing Devices
         2.1. Urine Testing Devices
         2.2. Oral Fluid Testing Devices
        3. Consumables

  • 9.  Drug of Abuse Testing Market, By Sample Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Saliva
        2. Urine
        3. Blood
        3. Other Sample Types

  • 10.   Drug of Abuse Testing Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Rehabilitation Centers
        3. Federal Agencies
        4. Forensic Laboratories
        5. Clinics
        6. Hospitals
        7. Others

  • 11.   Drug of Abuse Testing Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pain Management Testing
        2. Criminal Justice Testing
        3. Workplace Screening

  • 12.   North America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        12.3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    •   1. Thermo Fisher Scientific
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. SYNLAB
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Siemens Healthcare Private Limited
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Roche Diagnostics
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5 . Drägerwerk AGCo. KGaA
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Beckman Coulter, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Abbott Laboratorie
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Express Diagnostics International Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Shimadzu Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Alere Inc.,
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Laboratory Corporation of America Holdings
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Clinical Reference Laboratory (CRL), Inc
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Legacy Medical Services
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Millennium Health
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. American Substance Abuse Professional (ASAP), Inc
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client

Related Market

At-Home Drug of Abuse Market

Read More
Partner

Our Clients